Solid Malignancies clinical trials at UCSD

1 in progress, 0 open to eligible people

CFI-402411 in Subjects With Advanced Solid Malignancies
Sorry, in progress, not accepting new patients
The purpose of this study is to test the safety of an investigational drug called CFI-402411 alone and in combination with pembrolizumab and to study its effects in patients with advanced solid tumors who have progressed following previous therapies.
La Jolla, California and other locations

Last updated: May 16, 2025